Dr. Patricia A. Broderick, PhD is a Full, Medical Professor with Tenure at the City University of New York Medical School, Dept. of Molecular, Cellular and Biomedical Science, USA where she also holds faculty positions at the CUNY Grad Ctr.: Psychology: Cognitive and Behavioral Neuroscience as well as at CUNY Neuroscience Collaborative Graduate Program: Biology. Patricia served as the Director of Pharmacology at the City University of New York Physician Assistant/MS program at the CUNY Medical School and Director of the Neurobiology of Drugs of Abuse Course as well as Adjunct Professor in Neurology and the Comprehensive Epilepsy Center at NYU Langone Medical Center, USA. As graduate, doctoral, medical, physician assistant and high school mentor, her innovative teaching is deeply appreciated. As principal and founder of Eazysense Nanotechnologies Inc., the Broderick Brain Foundation Inc. and inventor of the BRODERICK PROBE® series of nanobiosensors and circuits, Patricia has garnered respect and admiration worldwide. Achieving her PhD in Pharmacology from St. John's University, College of Arts and Sciences, NY, USA, her expertise in the field of atomic absorption photometry and fluorescent spectrometry, her inventive neuroimaging art in the biosensing and bioimaging field at the Albert Einstein College of Medicine and Cornell University, NY, USA, makes sense. Indeed, as postdoctoral fellow, Dr. Broderick was awarded the Rosenbaum Award from Albert Einstein Medical School/Montefiore Hospital and her patents began at the Albert Einstein College of Medicine are now held by CUNY. Patricia has published and patented extensively and has garnered respect for her novel research around the world. The BRODERICK PROBE® trademark, named after her father, brings a solid brand as the nanoprobe is poised for marketing her unique cutting-edge nanotechnology in the field of Neuroscience. She is the recipient of multiple grants awards and prestigious honors from organizations such as Inner Circle Executives, Acquisitions International Global/Corporate America, International Association of Professionals, National Association of Distinguished Professionals and Top Industry Experts from Patient Preferred Physicians and Practitioners was celebrated in 2024. A pivotal figure in biosensing technology and the brain, spinal cord and the skin, Broderick served as Session Chair, at the Virtual International Electronic Conference on Brain Sciences, Beijing, October, 2024 and her pending 2025 patent application for replenishing skin as well as her multiple patents are recognized by major diagnostic and pharmaceutical markets, worldwide. Prof. Broderick serves on the editorial boards of several prestigious scientific and medical journals and her work as editor, author and lecturer is renowned. No stranger to the airways, Patricia is a sought-after speaker and her weekly talk show, The Eazysense Show, is at the top of the list at Bold Brave Media (BBM) Productions. Patricia's unwavering dedication to advancing the understanding of neurological, psychological and mental health is reflected in her latest launched textbook, Broderick PA (2025) NEUROIMAGING: Sensing Biochemistry in the Brain, Jenny Stanford Publishing, Pte Ltd., Singapore.The Editor thanks Springe Nature for the opportunity to lead the most talented and influential physicians and scientists in the world via this book, Biomedical Imaging in Neurodegeneration.